Drugmakers spent less on Washington lobbying in 2025’s final quarternews2026-01-22T18:35:32+00:00January 22nd, 2026|Endpoints News|
Another biopharma tried buying Amicus before BioMarin’s $4.8B dealnews2026-01-22T15:16:22+00:00January 22nd, 2026|Endpoints News|
#JPM26: Hua Medicine plots diabetes drug expansion in China and beyondnews2026-01-22T12:00:28+00:00January 22nd, 2026|Endpoints News|
The status of EU drug price talks depends on who you asknews2026-01-21T20:33:36+00:00January 21st, 2026|Endpoints News|
J&J praises new FDA guidance to speed development of multiple myeloma drugsnews2026-01-21T18:35:12+00:00January 21st, 2026|Endpoints News|
Johnson & Johnson brushes off MFN impact, sees strong growth for 2026news2026-01-21T16:43:28+00:00January 21st, 2026|Endpoints News|
#JPM26: Regeneron, Lilly, Summit on rivals crowding into same targetsnews2026-01-21T14:00:49+00:00January 21st, 2026|Endpoints News|
EU Parliament adopts stricter drug stockpiling rules under Critical Medicines Actnews2026-01-20T18:55:38+00:00January 20th, 2026|Endpoints News|
Valneva withdraws chikungunya vaccine from USnews2026-01-20T18:37:12+00:00January 20th, 2026|Endpoints News|
Clinician groups ask court to overturn CDC’s childhood vaccine overhaulnews2026-01-20T15:54:25+00:00January 20th, 2026|Endpoints News|
